Stay updated on Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial page.

Latest updates to the Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial page
- Check6 days agoChange DetectedAdded a site-wide funding-status notice and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check13 days agoChange DetectedThe page now includes a glossary toggle, adds a 'Last Update Submitted that Met QC Criteria' label, normalizes 'No FEAR Act Data' to 'No FEAR Act data', and updates the revision footer to v3.4.0.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.1%

- Check49 days agoChange DetectedAdded a Locations section with Illinois. Removed the Illinois Locations entry and the HHS Vulnerability Disclosure; page revision updated to v3.3.3.SummaryDifference0.2%

- Check70 days agoChange DetectedRevision: v3.3.2 is now shown (replacing v3.3.1) on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page revision tag was updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial page.